Abstract:The Fibroblast growth factor (FGFs) family consists of at least 22 members that exert their function by binding and activating fibroblast growth factor receptors (FGFRs). The Fgf8/FgfD subfamily member, Fgf17, is located on human chromosome 8p21.3 and mouse chromosome 14 D2. In humans, FGF17 can be alternatively spliced to produce two isoforms (FGF17a and b) whereas three isoforms are present in mice (Fgf17a, b, and c), however, only Fgf17a and Fgf17b produce functional proteins. Fgf17 is a secreted protein with a cleavable N-terminal signal peptide and contains two binding domains, namely a conserved core region and a heparin binding site. Fgf17 mRNA is expressed in a wide range of different tissues during development, including the rostral patterning centre, midbrain-hindbrain boundary, tailbud mesoderm, olfactory placode, mammary glands, and smooth muscle precursors of major arteries. Given its broad expression pattern during development, it is surprising that adult Fgf17-/- mice displayed a rather mild phenotype; such that mutants only exhibited morphological changes in the frontal cortex and mid/hind brain boundary and changes in certain social behaviours. In humans, FGF17 mutations are implicated in several diseases, including Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome. FGF17 mutations contribute to CHH/KS in 1.1% of affected individuals, often presenting in conjunction with mutations in other FGF pathway genes like FGFR1 and FLRT3. FGF17 mutations were also identified in patients diagnosed with Dandy-Walker malformation and Pituitary Stalk Interruption Syndrome, however, it remains unclear how FGF17 is implicated in these diseases. Altered FGF17 expression has been observed in several cancers, including prostate cancer, hematopoietic cancers (acute myeloid leukemia and acute lymphoblastic leukemia), glioblastomas, perineural invasion in cervical cancer, and renal cell carcinomas. Furthermore, FGF17 has demonstrated neuroprotective effects, particularly during ischemic stroke, and has been shown to improve cognitive function in ageing mice.

Fgf17: A regulator of the mid/hind brain boundary in mammals

Fgf17b, A Novel Member of Fgf Family, Helps Patterning Zebrafish Embryos

The Fundamentals of Fibroblast Growth Factor 9.

Fibroblast Growth Factor (FGF) 13

Characterization of FGF21 Sites of Production and Signaling in Mice

Spatiotemporal Expression of Fibroblast Growth Factor 10 in Human Hindgut and Anorectal Development

Fibroblast Growth Factor Receptor 2 (Fgfr2)-Mediated Reciprocal Regulation Loop Between FGF8 and FGF10 is Essential for Limb Induction

Patterning of frontal cortex subdivisions by Fgf17

FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy–Walker malformation carrying a de novo 8p deletion

Primer on fibroblast growth factor 7 (FGF 7)

FGF Ligand Family mRNA Expression Profile for Mouse Preimplantation Embryos, Early Gestation Human Placenta, and Mouse Trophoblast Stem Cells

Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection

Fibroblast Growth Factor Receptor-1 (Fgfr-1) Is Essential For Normal Neural Tube And Limb Development

Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives

Increased Production of Human Fibroblast Growth Factor 17 in Escherichia Coli and Proliferative Activity in NIH3T3 Cells.

Functional analysis of a first hindlimb positioning enhancer via Gdf11 expression

The Central Fibroblast Growth Factor Receptor/beta Klotho System: Comprehensive Mapping in Mus Musculus and Comparisons to Nonhuman Primate and Human Samples Using an Automated in Situ Hybridization Platform

Roles of FGF signaling in skeletal development and human genetic diseases.

Overexpression of Fgf18 in cranial neural crest cells recapitulates Pierre Robin sequence in mice

A Hypomorphic Allele in the FGF8 Gene Contributes to Holoprosencephaly and Is Allelic to Gonadotropin-Releasing Hormone Deficiency in Humans